Current Liabilities

Accrued interest

Neurocrine Biosciences Accrued interest increased by 6.8% to $21.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 51.0%, from $14.50M to $21.90M. Over 2 years (FY 2023 to FY 2025), Accrued interest shows an upward trend with a 35.3% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ1 2026May 5, 2026

How to read this metric

An increase typically tracks with the total debt load and the timing of interest payment cycles.

Detailed definition

Accrued interest represents the interest expense that has accumulated on debt obligations but has not yet reached its sc...

Peer comparison

Comparable across companies with similar capital structures and debt maturity profiles.

Metric ID: accrued_interest

Historical Data

9 periods
 Q4 '23Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$11.20M$12.60M$13.50M$14.40M$14.50M$16.70M$18.40M$20.50M$21.90M
QoQ Change+12.5%+7.1%+6.7%+0.7%+15.2%+10.2%+11.4%+6.8%
YoY Change+28.6%+32.5%+36.3%+42.4%+51.0%
Range$11.20M$21.90M
CAGR+39.8%
Avg YoY Growth+38.2%
Median YoY Growth+36.3%
Current Streak8+ quarters growth

Accrued interest at Other Companies

Frequently Asked Questions

What is Neurocrine Biosciences's accrued interest?
Neurocrine Biosciences (NBIX) reported accrued interest of $21.90M in Q1 2026.
How has Neurocrine Biosciences's accrued interest changed year-over-year?
Neurocrine Biosciences's accrued interest increased by 51.0% year-over-year, from $14.50M to $21.90M.
What is the long-term trend for Neurocrine Biosciences's accrued interest?
Over 2 years (2023 to 2025), Neurocrine Biosciences's accrued interest has grown at a 35.3% compound annual growth rate (CAGR), from $11.20M to $20.50M.
What does accrued interest mean?
Interest that has built up on debt but has not been paid yet.